소장자료
LDR | 05630cam a2200649Mu 4500 | ||
001 | 0100495117▲ | ||
003 | OCoLC▲ | ||
005 | 20201221170629▲ | ||
006 | m d ▲ | ||
007 | cr cnu---unuuu▲ | ||
008 | 140802s2014 xx o 000 0 eng d▲ | ||
020 | ▼a9780128016190 (electronic bk.)▲ | ||
020 | ▼a0128016191 (electronic bk.)▲ | ||
035 | ▼a(OCoLC)885123522▲ | ||
035 | ▼a817536▼b(N$T)▲ | ||
040 | ▼aEBLCP▼beng▼cEBLCP▼dN$T▲ | ||
050 | 4 | ▼aRC268.4▲ | |
066 | ▼c(S▲ | ||
072 | 7 | ▼aHEA▼x039000▼2bisacsh▲ | |
072 | 7 | ▼aMED▼x014000▼2bisacsh▲ | |
072 | 7 | ▼aMED▼x022000▼2bisacsh▲ | |
072 | 7 | ▼aMED▼x112000▼2bisacsh▲ | |
072 | 7 | ▼aMED▼x045000▼2bisacsh▲ | |
082 | 0 | 4 | ▼a616.99▼a616.99/4042▲ |
100 | 1 | ▼aAshkenazi, Avi.▲ | |
245 | 1 | 0 | ▼aRegulated Cell Death Part B▼h[electronic resource] :▼bNecroptotic, Autophagic and other Non-apoptotic Mechanisms.▲ |
260 | ▼aBurlington :▼bElsevier Science,▼c2014.▲ | ||
300 | ▼a1 online resource (379 p.)▲ | ||
500 | ▼aDescription based upon print version of record.▲ | ||
500 | ▼a3. Signaling Proteins Controlling Necroptosis Affect Assembly of the NLRP3 Inflammasome▲ | ||
505 | 0 | ▼aFront Cover; Regulated Cell Death Part B: Necroptotic, Autophagic and other Non-apoptotic Mechanisms; Copyright; Contents; Contributors; Preface; Chapter One: Assays for Necroptosis and Activity of RIP Kinases; 1. Introduction; 1.1. Distinguishing features of necroptotic cell death; 1.2. Pathways and mediators of necroptosis; 2. Cellular Models of Necroptosis; 2.1. Cell types (Table 1.1); 2.2. Inducers of necroptosis; 2.3. Inhibitors of necroptosis; 3. Measurement of Necroptotic Cell Death▲ | |
505 | 8 | ▼6880-01▼a5. Analysis of Necrosome Complex Formation5.1. Immunoprecipitation of necrosome complex (Fig. 1.8); 5.2. Immunoprecipitation of TNFR1 complex; 5.3. Assessment of necrosome formation by fluorescence microscopy; 6. Endogenous RIPK Autophosphorylation Assays (Fig. 1.9); 7. Analysis of Recombinant RIPK1 Kinase Activity and Inhibition by Necrostatins; 7.1. Expression and purification of recombinant RIP1 and RIP3; 7.2. Kinase-Glo assay (Fig. 1.10); 7.3. HTRF KinEASE assay (Fig. 1.11); 7.4. Fluorescence polarization assay (Fig. 1.12); 7.5. Thermomelt assay (Fig. 1.13); 8. Conclusions▲ | |
505 | 8 | ▼aAcknowledgmentsReferences; Chapter Two: IAP Family of Cell Death and Signaling Regulators; 1. Identification of IAPs, Structure, and Domain Function; 1.1. Discovery; 1.2. Domain structure-BIRs; 1.3. Domain structure-RING and UBA; 1.4. Domain structure-NACHT and enigmatic CARD; 2. IAP Proteins and Cell Death Pathways; 2.1. XIAP-Inhibitor of the intrinsic Bcl-2 blockable pathway; 2.2. XIAP-Caspase inhibitor; 2.3. Inhibition of cell death by c-IAP1 and c-IAP2; 2.4. IAP proteins and ubiquitin; 2.5. Regulation of signaling pathways by IAP proteins; 2.6. Targeting IAP proteins; References▲ | |
520 | ▼aRegulated Cell Death Part A & Part B of Methods in Enzymology continues the legacy of this premier serial with quality chapters authored by leaders in the field. This volume covers research methods in apoptosis focusing on the important areas of intrinsic pathway, extrinsic pathway, caspases, cellular assays and post-apoptotic effects and model organisms; as well as topics on necroptosis and screening approaches.Continues the legacy of this premier serial with quality chapters authored by leaders in the field Covers research methods in biomineralization s.▲ | ||
650 | 0 | ▼aCancer▼xMolecular aspects.▲ | |
650 | 0 | ▼aCancer▼xTreatment.▲ | |
650 | 0 | ▼aCell death.▲ | |
650 | 4 | ▼aCancer -- Molecular aspects.▲ | |
650 | 4 | ▼aCancer -- Treatment.▲ | |
650 | 4 | ▼aCell death.▲ | |
650 | 7 | ▼aHEALTH & FITNESS / Diseases / General▼2bisacsh▲ | |
650 | 7 | ▼aMEDICAL / Clinical Medicine▼2bisacsh▲ | |
650 | 7 | ▼aMEDICAL / Diseases▼2bisacsh▲ | |
650 | 7 | ▼aMEDICAL / Evidence-Based Medicine▼2bisacsh▲ | |
650 | 7 | ▼aMEDICAL / Internal Medicine▼2bisacsh▲ | |
655 | 4 | ▼aElectronic books.▲ | |
700 | 1 | ▼aWells, Jim.▲ | |
700 | 1 | ▼aYuan, Junying.▲ | |
776 | 0 | 8 | ▼iPrint version:▼aAshkenazi, Avi▼tRegulated Cell Death Part B : Necroptotic, Autophagic and other Non-apoptotic Mechanisms▼dBurlington : Elsevier Science,c2014▼z9780128014301▲ |
856 | 4 | 0 | ▼3EBSCOhost▼uhttp://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=817536▲ |
880 | 8 | ▼6505-00/(S▼aChapter Three: Activation of the NLRP3 Inflammasome by Proteins That Signal for Necroptosis1. Introduction; 2. Altered Expression or Function of Enzymes That Control Induction of Necroptosis Results in Altered Generation of IL-1棺...; 2.1. Generation of mouse bone marrow-derived DCs; 2.2. Use of transgenic mice to obtain DCs deficient in caspase-8 or RIPK3; 2.3. Knockdown of proteins signaling for necroptosis in DCs; 2.4. Induction of cytokines in DCs by agents inducing and activating the NLRP3 inflammasome; 2.5. Quantification of the induced cytokines▲ | |
880 | 8 | ▼6505-01/(S▼a3.1. Analysis of viability of FADD-deficient Jurkat cells treated with TNF慣 using CellTiter-Glo assay (Fig. 1.1)3.2. Determination of specific cell death using SYTOX Green assay (Fig. 1.2); 3.3. Annexin V/PI assay (Fig. 1.3); 3.4. Analysis of ROS increase (Fig. 1.4); 3.5. Mitochondrial membrane depolarization (Fig. 1.3); 3.6. Analysis of TNF慣 gene expression changes by qPCR (Fig. 1.5); 4. Recapitulation of RIP1 Kinase Expression in RIP1-Deficient Jurkat Cells; 4.1. Transient transfection (Fig. 1.6); 4.2. Generation of stable-inducible cell lines (Fig. 1.7)▲ | |
910 | ▼acpp1723AUTO▲ | ||
938 | ▼aEBL - Ebook Library▼bEBLB▼nEBL1754625▲ | ||
938 | ▼aEBSCOhost▼bEBSC▼n817536▲ | ||
994 | ▼a02▼bN$T▲ |
![](https://lib.pusan.ac.kr/lawlib/wp-content/themes/pnul2022/assets/images/default/default_w_279X393.png)
Regulated Cell Death Part B :Necroptotic, Autophagic and other Non-apoptotic Mechanisms
자료유형
국외eBook
서명/책임사항
Regulated Cell Death Part B [electronic resource] : Necroptotic, Autophagic and other Non-apoptotic Mechanisms.
발행사항
Burlington : Elsevier Science , 2014.
형태사항
1 online resource (379 p.)
일반주기
Description based upon print version of record.
3. Signaling Proteins Controlling Necroptosis Affect Assembly of the NLRP3 Inflammasome
3. Signaling Proteins Controlling Necroptosis Affect Assembly of the NLRP3 Inflammasome
내용주기
Front Cover; Regulated Cell Death Part B: Necroptotic, Autophagic and other Non-apoptotic Mechanisms; Copyright; Contents; Contributors; Preface; Chapter One: Assays for Necroptosis and Activity of RIP Kinases; 1. Introduction; 1.1. Distinguishing features of necroptotic cell death; 1.2. Pathways and mediators of necroptosis; 2. Cellular Models of Necroptosis; 2.1. Cell types (Table 1.1); 2.2. Inducers of necroptosis; 2.3. Inhibitors of necroptosis; 3. Measurement of Necroptotic Cell Death
5. Analysis of Necrosome Complex Formation5.1. Immunoprecipitation of necrosome complex (Fig. 1.8); 5.2. Immunoprecipitation of TNFR1 complex; 5.3. Assessment of necrosome formation by fluorescence microscopy; 6. Endogenous RIPK Autophosphorylation Assays (Fig. 1.9); 7. Analysis of Recombinant RIPK1 Kinase Activity and Inhibition by Necrostatins; 7.1. Expression and purification of recombinant RIP1 and RIP3; 7.2. Kinase-Glo assay (Fig. 1.10); 7.3. HTRF KinEASE assay (Fig. 1.11); 7.4. Fluorescence polarization assay (Fig. 1.12); 7.5. Thermomelt assay (Fig. 1.13); 8. Conclusions
AcknowledgmentsReferences; Chapter Two: IAP Family of Cell Death and Signaling Regulators; 1. Identification of IAPs, Structure, and Domain Function; 1.1. Discovery; 1.2. Domain structure-BIRs; 1.3. Domain structure-RING and UBA; 1.4. Domain structure-NACHT and enigmatic CARD; 2. IAP Proteins and Cell Death Pathways; 2.1. XIAP-Inhibitor of the intrinsic Bcl-2 blockable pathway; 2.2. XIAP-Caspase inhibitor; 2.3. Inhibition of cell death by c-IAP1 and c-IAP2; 2.4. IAP proteins and ubiquitin; 2.5. Regulation of signaling pathways by IAP proteins; 2.6. Targeting IAP proteins; References
5. Analysis of Necrosome Complex Formation5.1. Immunoprecipitation of necrosome complex (Fig. 1.8); 5.2. Immunoprecipitation of TNFR1 complex; 5.3. Assessment of necrosome formation by fluorescence microscopy; 6. Endogenous RIPK Autophosphorylation Assays (Fig. 1.9); 7. Analysis of Recombinant RIPK1 Kinase Activity and Inhibition by Necrostatins; 7.1. Expression and purification of recombinant RIP1 and RIP3; 7.2. Kinase-Glo assay (Fig. 1.10); 7.3. HTRF KinEASE assay (Fig. 1.11); 7.4. Fluorescence polarization assay (Fig. 1.12); 7.5. Thermomelt assay (Fig. 1.13); 8. Conclusions
AcknowledgmentsReferences; Chapter Two: IAP Family of Cell Death and Signaling Regulators; 1. Identification of IAPs, Structure, and Domain Function; 1.1. Discovery; 1.2. Domain structure-BIRs; 1.3. Domain structure-RING and UBA; 1.4. Domain structure-NACHT and enigmatic CARD; 2. IAP Proteins and Cell Death Pathways; 2.1. XIAP-Inhibitor of the intrinsic Bcl-2 blockable pathway; 2.2. XIAP-Caspase inhibitor; 2.3. Inhibition of cell death by c-IAP1 and c-IAP2; 2.4. IAP proteins and ubiquitin; 2.5. Regulation of signaling pathways by IAP proteins; 2.6. Targeting IAP proteins; References
요약주기
Regulated Cell Death Part A & Part B of Methods in Enzymology continues the legacy of this premier serial with quality chapters authored by leaders in the field. This volume covers research methods in apoptosis focusing on the important areas of intrinsic pathway, extrinsic pathway, caspases, cellular assays and post-apoptotic effects and model organisms; as well as topics on necroptosis and screening approaches.Continues the legacy of this premier serial with quality chapters authored by leaders in the field Covers research methods in biomineralization s.
주제
기타형태저록
ISBN
9780128016190 (electronic bk.) 0128016191 (electronic bk.)
관련 인기대출 도서